Doctors are now evaluating an investigational treatment designed to reduce pressure buildup inside the eye. The treatment involves an innovative device called the CyPass Micro-Stent
. Currently, this technology is only available in the U.S. through the COMPASS Clinical Study. The CyPass Micro-Stent has been available for clinical assessment in Europe since 2009.
The CyPass Micro-Stent is inserted in the eye during routine cataract surgery, just after the intraocular lens (or "IOL") is placed in the eye. Using specialized instrumentation, the CyPass Micro-Stent is placed in a precise location just below the surface of the eye to create a new pathway for the drainage of fluid, thereby reducing intraocular pressure. Once in place, the CyPass Micro-Stent is intended to control intraocular pressure all day long, which may reduce the risk of glaucoma disease progression.
The CyPass Micro-Stent is designed to create a
path for excess fluid to drain, thereby reducing intraocular pressure